No Data
No Data
Salubris Pharmaceuticals Gets Nod to Market Hypertension Drug
Shenzhen Salubris Pharmaceuticals (SHE:002294) received a drug registration certificate from China's National Medical Products Administration for allisartan medoxomil amlodipine tablets, according to
A Look At The Fair Value Of Shenzhen Salubris Pharmaceuticals Co., Ltd. (SZSE:002294)
Key Insights Shenzhen Salubris Pharmaceuticals' estimated fair value is CN¥30.19 based on 2 Stage Free Cash Flow to Equity Shenzhen Salubris Pharmaceuticals' CN¥28.70 share price indicates it is tra
Xinlitai (002294.SZ): Shareholder Runfu plans to donate 2 million shares free of charge to Ye Chenghai Charity Foundation
Gelonghui, May 13 | Xinlitai (002294.SZ) announced that the company recently received a “Notice Letter on Free Donation of Part of the Shares” from shareholder Shenzhen Runfu Investment and Development Co., Ltd. (hereinafter referred to as “Runfu”). It plans to donate 2 million shares (0.18% of the company's total share capital) held free of charge to Shenzhen Ye Chenghai Charity Foundation (hereinafter referred to as the “Foundation”). All proceeds from the sale of shares of the Foundation will be used to donate funds to public welfare undertakings such as financial aid. Among them, a targeted donation of not less than 50 million yuan will be made to Shenzhen University, and the remaining amount will be used for the Foundation to develop charity
Shenzhen Salubris Pharmaceuticals Co., Ltd.'s (SZSE:002294) On An Uptrend But Financial Prospects Look Pretty Weak: Is The Stock Overpriced?
Shenzhen Salubris Pharmaceuticals' (SZSE:002294) stock is up by a considerable 18% over the past three months. We, however wanted to have a closer look at its key financial indicators as the markets
Salubris Pharmaceuticals to Raise Capital of US Unit by $35 Million
Shenzhen Salubris Pharmaceuticals (SHE:002294) will inject an additional $35 million into the capital of its US unit, Salubris Biotherapeutics, the company said in its filing on the Shenzhen Stock Exc
Xinlitai (002294.SZ) plans to increase Salubris Bio's capital with self-financing of 35 million US dollars
Xinlitai (002294.SZ) announced that Salubris Biotherapeuti...
No Data